Sternberg CN - Search Results

1

Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma.

Iacovelli R, Farcomeni A, Sternberg CN, Cartenì G, Milella M, Santoni M, Cerbone L, Di Lorenzo G, Verzoni E, Ortega C, Sabbatini R, Ricotta R, Messina C, Lorusso V, Atzori F, De Vincenzo F, Sacco C, Boccardo F, Valduga F, Massari F, Baldazzi V, Cinieri S, Mosca A, Maria Ruggeri E, Berruti A, Procopio G. Iacovelli R, et al. Among authors: sternberg cn. J Urol. 2015 Jun;193(6):1905-10. doi: 10.1016/j.juro.2014.11.092. Epub 2014 Nov 26. J Urol. 2015. PMID: 25433306

2

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Morse MJ, Sogani PC, Vaughan ED Jr, Bander N, Weiselberg LR, et al. Sternberg CN, et al. J Urol. 1988 Mar;139(3):461-9. doi: 10.1016/s0022-5347(17)42494-3. J Urol. 1988. PMID: 3343727

3

Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results.

Pansadoro V, Emiliozzi P, Defidio L, Donadio D, Florio A, Maurelli S, Lauretti S, Sternberg CN. Pansadoro V, et al. Among authors: sternberg cn. J Urol. 1995 Dec;154(6):2054-8. J Urol. 1995. PMID: 7500457

4

Adjuvant chemotherapy following radical cystectomy.

Sternberg CN. Sternberg CN. World J Urol. 1993;11(3):169-74. doi: 10.1007/BF00211414. World J Urol. 1993. PMID: 8401637 Review.

5

Treatment of brain metastases from bladder cancer.

Rosenstein M, Wallner K, Scher H, Sternberg CN. Rosenstein M, et al. Among authors: sternberg cn. J Urol. 1993 Mar;149(3):480-3. doi: 10.1016/s0022-5347(17)36123-2. J Urol. 1993. PMID: 8437250

6

Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guérin: 18-year experience.

Pansadoro V, Emiliozzi P, de Paula F, Scarpone P, Pansadoro A, Sternberg CN. Pansadoro V, et al. Among authors: sternberg cn. Urology. 2002 Feb;59(2):227-31. doi: 10.1016/s0090-4295(01)01603-x. Urology. 2002. PMID: 11834391

7

High-risk metastatic urothelial cancer: chances for cure?

Calabrò F, Sternberg CN. Calabrò F, et al. Among authors: sternberg cn. Curr Opin Urol. 2002 Sep;12(5):441-8. doi: 10.1097/00042307-200209000-00013. Curr Opin Urol. 2002. PMID: 12172434 Review.

8

Metastatic renal cell cancer treatments.

Sternberg CN. Sternberg CN. Drugs Today (Barc). 2003;39 Suppl C:39-59. Drugs Today (Barc). 2003. PMID: 14988745 Review.

9

New treatments for metastatic kidney cancer.

Mancuso A, Sternberg CN. Mancuso A, et al. Among authors: sternberg cn. Can J Urol. 2005 Feb;12 Suppl 1:66-70; discussion 105. Can J Urol. 2005. PMID: 15780170 Review.

10

New treatment approaches in metastatic renal cell carcinoma.

Mancuso A, Sternberg CN. Mancuso A, et al. Among authors: sternberg cn. Curr Opin Urol. 2006 Sep;16(5):337-41. doi: 10.1097/01.mou.0000240305.78205.77. Curr Opin Urol. 2006. PMID: 16905978 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

444 results

Search Page